Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

The FDA proposed a new registration pathway on July 10, 2026, for distributed manufacturing networks that operate through a hub-and-spoke model. If finalized, the FDA distributed manufacturing rule would let qualifying networks register as one establishment instead of registering every